GB0323258D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB0323258D0
GB0323258D0 GBGB0323258.4A GB0323258A GB0323258D0 GB 0323258 D0 GB0323258 D0 GB 0323258D0 GB 0323258 A GB0323258 A GB 0323258A GB 0323258 D0 GB0323258 D0 GB 0323258D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0323258.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB0323258.4A priority Critical patent/GB0323258D0/en
Publication of GB0323258D0 publication Critical patent/GB0323258D0/en
Priority to US10/957,251 priority patent/US7655675B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0323258.4A 2003-10-04 2003-10-04 Therapeutic compounds Ceased GB0323258D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0323258.4A GB0323258D0 (en) 2003-10-04 2003-10-04 Therapeutic compounds
US10/957,251 US7655675B2 (en) 2003-10-04 2004-10-01 Gamma-secretase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0323258.4A GB0323258D0 (en) 2003-10-04 2003-10-04 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB0323258D0 true GB0323258D0 (en) 2003-11-05

Family

ID=29415512

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0323258.4A Ceased GB0323258D0 (en) 2003-10-04 2003-10-04 Therapeutic compounds

Country Status (2)

Country Link
US (1) US7655675B2 (en)
GB (1) GB0323258D0 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0120347D0 (en) 2001-08-21 2001-10-17 Merck Sharp & Dohme Therapeutic agents
GB0223039D0 (en) * 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US9567396B2 (en) 2006-03-07 2017-02-14 Evonik Degussa Gmbh Notch inhibition in the prevention of vein graft failure
US8133857B2 (en) * 2006-03-07 2012-03-13 The Brigham and Women's FHospital, Inc. NOTCH inhibition in the treatment of atherosclerosis
US8609897B2 (en) * 2009-02-06 2013-12-17 Merck Sharp & Dohme Corp. Trifluoromethylsulfonamide gamma secretase inhibitor
EP2413932A4 (en) 2009-04-01 2012-09-19 Merck Sharp & Dohme Inhibitors of akt activity
EP2493497A4 (en) 2009-11-01 2013-07-24 Brigham & Womens Hospital Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
EP2693880A1 (en) 2011-04-04 2014-02-12 Merck Sharp & Dohme Corp. Gamma secretase inhibitors
WO2013059302A1 (en) 2011-10-17 2013-04-25 Nationwide Children's Hospital, Inc. Products and methods for aortic abdominal aneurysm
WO2020016377A1 (en) 2018-07-19 2020-01-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination for treating cancer
WO2020033282A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
EP3833667B1 (en) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Prmt5 inhibitors
US20230416830A1 (en) 2020-11-16 2023-12-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for predicting and treating uveal melanoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773273B2 (en) 1999-02-26 2004-05-20 Bristol-Myers Squibb Company Novel sulfonamide compounds and uses thereof
US7365196B2 (en) 2000-03-20 2008-04-29 Merck Sharp & Dohme Ltd. Sulphonamido-substituted bridged bicycloalkyl derivatives
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
AU2002324123B2 (en) 2001-08-21 2007-07-12 Merck Sharp & Dohme (Uk) Limited Novel cyclohexyl sulphones
GB0223038D0 (en) * 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds

Also Published As

Publication number Publication date
US7655675B2 (en) 2010-02-02
US20050075320A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
HU0302451D0 (en) New compounds with therapeutic effect
GB0307918D0 (en) Therapeutic use
GB0303910D0 (en) Therapeutic agents
GB0308318D0 (en) Therapeutic agents
GB0324886D0 (en) Medicinal compounds
GB0314057D0 (en) Therapeutic agents
GB0303396D0 (en) Medicinal compounds
GB0313250D0 (en) Therapeutic agents
GB0323258D0 (en) Therapeutic compounds
GB0314049D0 (en) Therapeutic agents
GB0311859D0 (en) Therapeutic agents
GB0328490D0 (en) Medicinal compounds
GB0301350D0 (en) Therapeutic agents
AU2003215150A8 (en) Therapeutic compounds
GB0304524D0 (en) Therapeutic agents
GB0208392D0 (en) Therapeutic compounds
GB0327426D0 (en) Therapeutic compounds
GB0327425D0 (en) Therapeutic compounds
GB0315140D0 (en) Therapeutic compounds
GB0325021D0 (en) Therapeutic combinations
GB0201509D0 (en) Therapeutic Compounds
GB0200135D0 (en) Therapeutic Compounds
GB0219721D0 (en) Therapeutic compounds
GB0200134D0 (en) Therapeutic compounds
GB0200136D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)